Latest News and Press Releases

PRINCETON, NJ--(Marketwire - Sep 24, 2012) - Agile Therapeutics today announced findings from a phase III pivotal trial of AG200-15, Agile's investigational once-weekly combination contraceptive...

PRINCETON, NJ--(Marketwire - Sep 20, 2012) -  Agile Therapeutics announced today that Dr. Marie Foegh, Chief Medical Officer and Vice President of Clinical Research and Development, will be...

YOQNEAM, ISRAEL--(Marketwire - Sep 19, 2012) - Given Imaging (NASDAQ: GIVN), a world leader in specialty GI products and pioneer of capsule endoscopy, today announced that it has filed for...

PARIS--(Marketwire - Sep 18, 2012) - Mauna Kea Technologies (NYSE Euronext: MKEA), leader in the endomicroscopy market and developer of Cellvizio® imaging, the fastest way to see cancer, today...

YOQNEAM, ISRAEL--(Marketwire - Sep 11, 2012) - Given Imaging (NASDAQ: GIVN) today announced that Homi Shamir, President and CEO, will present at the UBS Global Life Sciences Conference taking place...

PARIS--(Marketwire - Sep 10, 2012) -  Mauna Kea Technologies (NYSE Euronext: MKEA), leader in the endomicroscopy market and developer of Cellvizio® imaging, the fastest way to see cancer,...

BEDFORD, MA--(Marketwire - Sep 7, 2012) -  Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, today announced...

PARIS--(Marketwire - Sep 4, 2012) - Mauna Kea Technologies (NYSE Euronext: MKEA), leader in the endomicroscopy market and developer of Cellvizio® imaging, the fastest way to see cancer, today...

PARIS--(Marketwire - Aug 30, 2012) -  Mauna Kea Technologies (EURONEXT PARIS: MKEA) 93% sales growth during first half Accelerated investment in sales...

YOQNEAM, ISRAEL--(Marketwire - Aug 30, 2012) - Given Imaging (NASDAQ: GIVN) today announced that Yuval Yanai, Chief Financial Officer, and David Mason, MD, Chief Medical Officer, will present at...